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Background: Cellular senescence is a stress response of mammalian cells leading to a durable arrest of cell
proliferation that has been implicated in tumor suppression, wound healing, and aging. The proliferative arrest is
mediated by transcriptional repression of genes essential for cell division by the retinoblastoma protein family. This
repression is accompanied by varying degrees of heterochromatin assembly, but little is known regarding the
molecular mechanisms involved.
Results: We found that both deacetylation of H4-K16Ac and expression of HMGA1/2 can contribute to DNA
compaction during senescence. SIRT2, an NAD-dependent class III histone deacetylase, contributes to H4-K16Ac
deacetylation and DNA compaction in human fibroblast cell lines that assemble striking senescence-associated
heterochromatin foci (SAHFs). Decreased H4-K16Ac was observed in both replicative and oncogene-induced
senescence of these cells. In contrast, this mechanism was inoperative in a fibroblast cell line that did not assemble
extensive heterochromatin during senescence. Treatment of senescent cells with trichostatin A, a class I/II histone
deacetylase inhibitor, also induced rapid and reversible decondensation of SAHFs. Inhibition of DNA compaction
did not significantly affect the stability of the senescent state.
Conclusions: Variable DNA compaction observed during senescence is explained in part by cell-type specific
regulation of H4 deacetylation and HMGA1/2 expression. Deacetylation of H4-K16Ac during senescence may
explain reported decreases in this mark during mammalian aging and in cancer cells.Background
Genomic DNA in eukaryotes is packaged into chroma-
tin. The histones and non-histone proteins of chromatin
compact the DNA and govern its accessibility to
enzymes during transcription, replication, repair and re-
combination. Poorly transcribed regions of the genome
are typically found in highly compacted DNA as hetero-
chromatin, whereas transcribed sequences are found in
the more accessible euchromatin [1]. Post-translational
modifications of histones represent an important mech-
anism modulating the accessibility of chromatin and
contributing to the recruitment of other proteins to
chromatin [2]. Histones are extensively modified princi-
pally by acetylation, methylation, ubiquitylation, and
phosphorylation. Euchromatin is enriched in histones* Correspondence: carl.mann@cea.fr
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distribution, and reproduction in any mediumacetylated at lysine residues. Acetylation of H4-K16 plays
a particularly important, evolutionarily conserved role in
regulating chromatin compaction [3]. Positively charged
H4-K16 can form a salt bridge with acidic patches of
H2A and H2B on adjacent nucleosomes and thereby
contribute to folding of the chromatin fiber in vitro [4-6].
Acetylation of H4-K16 neutralizes its basic charge and
inhibits compaction of the chromatin. Acetylation of H4-
K16 can also recruit specific bromodomain-containing
proteins to chromatin to stimulate transcription [7].
Consistent with these attributes, unacetylated H4-K16 is
generally associated with transcriptional silencing and
heterochromatin, whereas H4-K16Ac is generally asso-
ciated with euchromatin [3]. In budding yeast, hetero-
chromatin is formed by the localized action of the Sir2
NAD-dependent histone deacetylase that specifically
deacetylates H4-K16Ac to allow binding of the SIR silen-
cing complex [8]. In mammals, X chromosome dosage
compensation involves heterochromatization and tran-
scriptional silencing of one of two copies of the Xtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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on this inactive X chromosome [9]. In contrast, in Dros-
ophila, X chromosome dosage compensation involves
hyperacetylation of H4-K16 on the single male X
chromosome by the MOF (MYST1/KAT8) histone acet-
yltransferase to increase its transcriptional output relative
to the two female X chromosomes [10].
In mammals, several members of the MYST family of
histone acetyltransferases are able to acetylate H4-K16,
but MOF is principally responsible for the global levels
of H4-K16Ac [11,12]. Homozygous MOF knockout mice
die during early embryogenesis [13]. Depletion of MOF
in mouse or human fibroblasts leads to striking
decreases in H4-K16Ac accompanied by abnormal nu-
clear and mitotic figures [12,14]. Acetylation of H4-K16
by MOF is important for activation of checkpoint path-
ways in response to DNA damage and for efficient DNA
repair [12,14,15]. Global acetylation of H4-K16 in mam-
mals is countered by both class I (HDAC1 and HDAC2)
and class III histone deacetylases (SIRT1 and SIRT2) in
different contexts [16-18]. HDAC1/2 and SIRT1 are
largely nuclear enzymes. In contrast, SIRT2 shuttles con-
tinuously between the nucleus and cytoplasm, but is
largely cytoplasmic at steady state during the interphase
of the cell cycle [19]. SIRT2 has an important role in
globally deacetylating H4-K16Ac during mitosis [16].
Heterochromatin assembly is associated with many
forms of cellular senescence [20]. Senescence is a stress
response of mammalian cells induced by numerous
stimuli including telomere loss, oncogene activation, and
genotoxic agents [21]. Senescent cells are metabolically
active, but do not proliferate in response to mitogenic
stimuli. Accumulating evidence shows that senescence
has a critical role in tumor suppression, wound healing,
and aging in vivo [22]. Although a biomarker totally spe-
cific to senescent cells has not been identified, senescent
human cells often display some common characteristics
including cell cycle arrest mediated by the p53 and/or
Rb tumor suppressor pathways, morphological changes,
induction of SA-β-galactosidase activity, enhanced secre-
tion of some cytokines and metalloproteases, and het-
erochromatin assembly that may include the formation
of highly compacted DNA in the form of senescence-
associated heterochromatin foci (SAHFs) [21,22]. SAHFs
are facultative heterochromatin that are specifically
enriched in the transcriptionally silent H3K9Me3 histone
mark, whereas euchromatic marks such as H3K9Ac and
H3K4Me are largely excluded from these foci [23].
HMGA1, HMGA2, HP1, and macro-H2A were found to
be associated with SAHFs, whereas some histone H1
variants were depleted from the chromatin of senescent
cells [24-26]. HMGA1 and the histone chaperone ASF1a
have been implicated in the induction of fibroblast sen-
escence and the assembly of heterochromatin, but theirprecise functions are not known [24,26]. Given the dra-
matic chromatin reorganization/compaction observed in
senescent cells, we postulated that some abundant his-
tone post-translational modifications (PTMs) could vary
to favor SAHFs formation. We discovered that a signifi-
cant fraction of H4-K16Ac was deacetylated in senes-
cence and contributed to heterochromatin assembly and
maintenance in fibroblast lines that were competent to
form SAHFs.
Results
Loss of H4-K16 acetylation is specific to senescent cells
and correlates with DNA compaction
Heterochromatin assembly has been associated with
many forms of cellular senescence. In the most extreme
cases, senescence induced by oncogene expression is ac-
companied by the formation of striking SAHFs that are
readily visible by 40,60-diamidino-2-phenylindole (DAPI)
staining. For example, expression of an activated RAS
oncogene (RASval12) induces senescence with SAHFs
in many human fibroblasts [23]. Moreover, expression
of an activated oncogenic form of the B-RAF kinase
(B-RAF-V600E) induces senescence with SAHFs in
human melanocytes [27]. Such highly condensed masses
of heterochromatin are not normally seen in proliferating
human cells aside from the Barr body (inactive X chromo-
some) in female cells. We used mass spectrometry (MS)
protein profiling [28] to monitor many histone variants
and their modification by acetylation, methylation, or
phosphorylation. We compared histone profiles from pro-
liferative, quiescent and senescent cells. Senescence was
induced by three different stresses: expression of an acti-
vated form of the RAF1 (C-RAF) kinase, telomere short-
ening (replicative senescence) and genotoxic stress
(etoposide, a topoisomerase II inhibitor that provokes
DNA double-strand breaks). We monitored bromodeoxy-
uridine (BrdU) incorporation, FACS (Fluorescence
Activated Cell Sorting) profiles, and SA-β-galactosidase
expression in each of these experimental conditions to
confirm the expected effects of each treatment on cell
proliferation, cell cycle profiles, and senescent marker
expression (Figures 1A and 2A).
Our reference population was proliferating hTERT-
immortalized WI-38 human embryonic lung fibroblasts
grown in 5% oxygen. These cells are free from stress
engendered by telomere attrition or growth under
hyper-physiological 20% ambient oxygen. They also
expressed an activated form of the RAF1 kinase fused to
green fluorescent protein (GFP) and the estrogen recep-
tor domain (GFP-RAF-ER) that could be activated with
4-hydroxy-tamoxifen (4-HT). Activation of the RAF1
kinase in these cells leads to a rapid hyper-stimulation of
the ERK1/2 mitogen-activated protein kinase pathway
that induces senescence accompanied by striking SAHFs
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Figure 1 (See legend on next page.)
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Figure 1 Loss of H4-K16 acetylation is specific to senescent cells and correlates with DNA compaction. A) DNA content by flow
cytometry. The percentage of cells incorporating bromodeoxy-uridine (BrdU) after 24 hours of incubation is indicated. B) DNA 4',6'-diamidino-2-
phenylindole (DAPI) staining of representative nuclei and corresponding DAPI coefficient of variation (CV) values. C) Boxplots of DAPI CV (n > 70,
from one representative experiment of two biological replicates). *DNA compaction statistically different from Prolif. or PD 43 (P< 10-5, Welch t-
test). D) Relative abundance of H4 acetylation states measured at the protein level on deconvoluted mass spectra (Figure 3). Error bars show SD
of at least three biological replicates. Prolif.: proliferating WI-38hTERT/GFP-RAF-ER; SenRAF: WI-38hTERT/GFP-RAF-ER + 20 nM 4-HT (5 days);
Quiescent: serum-starved WI-38hTERT/GFP-RAF-ER (5 days); SenETO: WI-38hTERT/GFP-RAF-ER+ 20 μM etoposide (5 days); Control 4-HT: WI-
38hTERT+ 20 nM 4-HT (5 days); PD 43: population doubling 43, proliferating WI-38 cells; PD 65: replicatively senescent WI-38 population.
Contrepois et al. Epigenetics & Chromatin 2012, 5:15 Page 4 of 19
http://www.epigeneticsandchromatin.com/content/5/1/15within 3 days [29]. We prepared chromatin from WI-
38hTERT/GFP-RAF-ER cells treated with 4-HT for
5 days, at which time prominent SAHFs had been well
established for 2 days (Figure 1B). This sample allowed
us to search for modifications of chromatin in senescent
cells with highly compacted heterochromatin. Chroma-
tin compaction in quiescent cells was not distinguishable
from that of proliferating cells (Figure 1B,C) using the
coefficient of variation (CV) of DAPI staining (DAPI
CV) within the nucleus as a quantitative metric of DNA
compaction in individual cells (see the Methods section).
The chromatin of senescent cells treated with etoposide
was less highly compacted than for RAF-induced senes-
cence (Figure 1B,C). Chromatin from proliferating non-
immortalized WI-38 fibroblasts at population doubling
(PD) 43, and from a culture at PD 65, was also prepared.
Most PD 65 cells had experienced replicative senescence
as shown by the inhibition of BrdU incorporation









Figure 2 A) Bright field pictures of WI-38 fibroblasts showing SA-β-ga
microscopy images of WI-38 fibroblasts showing 4',6'-diamidino-2-phenylin
proliferating (PD 43) and replicatively senescent cells (PD 65).but not PD 43 cells, also stained strongly positive for
phospho-H2AX and phospho-T68-Chk2 (Figure 2B),
markers of an activated DNA damage checkpoint, as
expected for replicatively senescent cells containing de-
fective telomeres [30]. Chromatin in senescent PD 65
cells was more compact than in cells treated with etopo-
side for 5 days, but less than in cells induced into senes-
cence by active RAF1 for 5 days (Figure 1B,C).
Analysis of the histone variants and PTMs by our pro-
filing method revealed surprisingly few differences in the
relative abundance of the predominant histone isoforms
when comparing the different samples (Figure 3). How-
ever, we noticed that H3.1 was more highly modified by
methylation and/or acetylation in non-proliferating cells
(senescence and quiescence) compared to cycling cells.
Since this effect was not specific to senescent cells, we
did not pursue the analysis of H3.1.
The most striking effect we observed was a significant
and specific decrease in histone H4 lysine acetylation in8-Chk2 phospho-H2AX 
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Figure 3 Deconvoluted mass spectra of intact core histones H4, H2B, H2A1, H2A2 and H3.1 extracted from WI-38 fibroblasts under the
indicated experimental conditions. For each acetylation state of H4, unmodified, mono- and di-methylated K20 forms are visible.
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approximately 55 to 60% of H4 was unacetylated on ly-
sine, approximately 35 to 40% was mono-acetylated,
and approximately 5 to 10% was di-acetylated. In senes-
cent cells, H4-lysine mono-acetylation was decreased by
at least 25 to 30% (Figure 1D). Although this represents
a modest relative decrease, in absolute amounts it repre-
sents the very substantial deacetylation of 6 million
molecules of H4 per cell (A diploid human cell contains
approximately 30 million nucleosomes and thus 60 mil-
lion molecules of H4, of which about 24 million mole-
cules are acetylated in proliferating cells and 18 million
molecules in senescent cells). This decreased acetylation
was confirmed by MS analyses on the Gly4-Arg17 tryptic
peptide (Figure 4). H4 acetylation varies during the cell
cycle, being lower in M/G1 and increasing in S/G2 cells
[16,31,32]. H4 deacetylation in senescence could thus be
an indirect consequence of the proliferative arrest. How-
ever, decreased H4 lysine acetylation was not detected in
quiescent cells (Figure 1D) that were similarly blocked in
their proliferation (Figure 1A), indicating that decreased
H4 acetylation is specific to the senescent state.Deacetylation of H4 mainly occurs on K16 during
senescence
H4 can be acetylated on four lysine residues: K5, K8, K12
and K16 [33]. We used MS/MS analysis of the H4 Gly4-
Arg17 tryptic peptide to identify the lysine residues that
are preferentially deacetylated during RAF senescence.
Previous work showed that the relative distribution of
acetylated lysine residues could be determined by meas-
uring the ratio of specific MS/MS peptide fragments
[34]. In the fraction of mono-acetylated H4 Gly4-Arg17
peptides, 83.5% and 82.3% were acetylated on K16 in pro-
liferating and senescent cells, respectively (Figure 5A,B).
Most of the remaining peptides were acetylated on K12.
Since the relative ratio of positional acetyl-lysine isoforms
of H4 is similar in proliferating and senescent cells, the
deacetylation observed in senescence must occur in rela-
tive proportion to the abundance of these isoforms.
This conclusion was independently confirmed by im-
munoblotting using antibodies specific for H4-K16Ac
and H4-K12Ac (Figure 5C). In contrast, the acetyl-
ation of H4-K8 did not vary significantly between
proliferating and senescent cells.
Figure 4 Relative abundance of H4 acetylation states measured
on the Gly4-Arg17 peptide by mass spectrometry (MS) analyses.
Error bars show SD of at least three biological replicates. Prolif.:
proliferating WI-38hTERT/GFP-RAF-ER; SenRAF: WI-38hTERT/GFP-RAF-
ER + 20 nM 4-HT (5 days); Quiescent: serum-starved WI-38hTERT/GFP-
RAF-ER (5 days); SenETO: WI-38hTERT/GFP-RAF-ER + 20 μM etoposide
(5 days); Control 4-HT: WI-38hTERT + 20 nM 4-HT (5 days); PD 43:
population doubling 43, proliferating WI-38 cells; PD 65: replicatively
senescent WI-38 population.
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acetylation level and DNA compaction during RAF-
induced senescence
Remarkably, deacetylation of H4-K16Ac is implicated in
transcriptional silencing and heterochromatin formation
from yeast to man [5,35]. We thus explored its role in
heterochromatin assembly during RAF-induced senes-
cence of human fibroblasts. Histone acetylation has a
rapid turnover due to the highly dynamic equilibrium
between histone acetyl transferase (HAT) and histone
deacetylase (HDAC) activities [36]. Previous work sug-
gested that MOF (MYST1/KAT8) is the key HAT re-
sponsible for the bulk global acetylation of H4-K16 in
mammals [11,12]. The importance of MOF activity in
global H4-K16 acetylation and DNA compaction was
confirmed by mRNA depletion concomitant with the in-
duction of RAF-induced senescence. Under these condi-
tions, we observed an enhanced loss of H4-K16
acetylation during senescence (Figure 6A) accompanied
by increased DNA compaction and even more promin-
ent SAHFs (Figures 6B and 7A,B). We saw no decrease
in MOF levels during RAF-induced senescence of
WI-38hTERT fibroblasts (Figure 6D). However, wecannot rule out that the activity of the MOF complex is
inhibited by some other mechanism during cellular
senescence.
We next sought to determine the role of HDACs in
H4-K16Ac deacetylation during senescence. Previous
work indicates a complex situation in which several dis-
tinct HDACs including SIRT1 [17], SIRT2 [16], HDAC1
and HDAC2 [18] may contribute to deacetylation of H4-
K16Ac depending on the experimental context. Highly
effective depletion of SIRT1 levels by siRNA treatment
did not inhibit deacetylation of H4-K16Ac or DNA com-
paction in RAF-senescent cells (Figures 6A,B and 7A,B).
Moreover, we saw no significant and reproducible
change in SIRT1 levels during RAF-induced senescence
(Figure 6D). Thus, SIRT1 is not an important global
regulator of H4-K16Ac and DNA compaction under
these conditions. In contrast, we noticed a slight but
reproducible increase in SIRT2 levels at early times
(6–24 h) after GFP-RAF-ER kinase activation by 4-HT
(Figure 6D). Interestingly, this early slight increase in
SIRT2 level was correlated with a similarly precocious
and gradual decrease in H4 acetylation and increase in
DNA compaction (Figure 6E,F).
We tested the effect of SIRT2 depletion by siRNAs on
the level of H4-K16Ac deacetylation and DNA compac-
tion during RAF-induced senescence. SIRT2 mRNAs
were successfully depleted by approximately 80%
(Figure 6C). Despite the clear decrease in SIRT2 mRNA,
depletion at the protein level was modest (Figure 6A). In
our model of RAF-induced senescence, cell division is
inhibited within one cell doubling [29], thus limiting the
possibility of dilution of the protein over time. The poor
depletion of SIRT2 protein suggests that it is quite stable
in these conditions. Despite the weak depletion, an
increase of H4-K16Ac was reproducibly observed
(Figure 6A) and was correlated with a significantly
lower DNA compaction in the SIRT2 siRNA-treated
cells (Figures 6B and 7A,B). SIRT2 depletion did not
affect the induction of senescence by activated RAF
kinase (Table 1). It is striking that modest decreases
in MOF or SIRT2 led to easily visible effects on H4-
K16 acetylation and DNA compaction, whereas strong
depletion of SIRT1 had no discernable effect on glo-
bal H4-K16 acetylation or DNA compaction.
We confirmed a role for sirtuins in H4-K16Ac
deacetylation and DNA compaction by treating cells
with the sirtuin inhibitors sirtinol and salermide dur-
ing RAF-induced senescence. Sirtinol and salermide
inhibit both SIRT1 [37] and SIRT2 [38]. Neither of
these molecules inhibited the RAF-induced prolifera-
tive arrest (Table 1), but they both blocked deacety-
lation of H4-K16Ac and inhibited DNA compaction
in the RAF-senescent cells (Figure 7C,D,E). Since
SIRT1 depletion had no effect on these processes, it
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duced an effect that was similar to mRNA depletion





























Figure 5 (See legend on next page.)We also tested the effect of SIRT2 siRNA treatment
on the stability of the senescent state. WI-38hTERT/
GFP-RAF-ER cells were transfected with SIRT2 or NoProlif.: 83.5% 
acetylated on K16 
SenRAF: 82.3% 
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Figure 5 H4 is mainly deacetylated on K16. A) MS/MS spectrum of the mono-acetylated H4 tryptic peptide Gly4-Arg17 (m/z 768.946) from a
SenRAF sample. Two rounds of propionylation were performed before and after trypsin digestion to propionylate free unmodified lysines and N-
termini. Consequently, the 14 Da differences shown in y5
+ and b9
+ fragment ions represent the mass difference between acetylated and
propionylated lysine. The spectrum is a mean of ten experiments along the chromatographic peak. Acetylation on K16 is calculated based on the
ratio of the specific daughter ions y5
+ and b9
+ shown as insert in Prolif. and SenRAF samples. K16Ac abundance is the mean of three independent
biological replicates (mean coefficient of variation, CV= 3.2%). B) Relative distribution of lysine acetylation on mono-acetylated H4 calculated from
the MS/MS spectra on Gly4-Arg17 tryptic peptides. The relative abundances of H4 mono-acetylation come from Figure 1D. C) Immunoblot
showing the levels of H4-K8Ac, H4-K12Ac and H4-K16Ac in acid-extracted histones. Loading control: Coomassie blue staining of histones. Prolif.:
proliferating WI-38hTERT/GFP-RAF-ER; SenRAF: WI-38hTERT/GFP-RAF-ER + 20 nM 4-HT.
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treatment with 20 nM 4-HT for 3 days. Senescent cells
were then transfected with No Target siRNA or siRNAs
to p16, or p21, or p16 + p21, and cells were incubated
for a further 3 days before testing the maintenance of
senescence by the capacity of cells to incorporate BrdU
during an additional 24-hour incubation. We previously
showed that knockdown of p16, or p21, or p16 + p21 can
partially reverse RAF-induced senescence [29]. Despite
decreased DNA compaction, we observed no significant
increase in reversion of RAF-senescent cells treated with
SIRT2 siRNAs (Figure 8). Thus, SIRT2 contributes to as-
sembling senescence-associated heterochromatin, but
may not be required for maintenance of the senescent
state.
Class I HDACs contribute to deacetylation of H4-K16Ac
and DNA compaction in senescent cells
The HDAC1 and HDAC2 class I histone deacetylases
have also been implicated in regulating global levels
of H4-K16Ac [18]. Trichostatin A (TSA) is a potent
inhibitor of class I and class II HDACs, but not class
III (sirtuins) [39]. Treatment of human fibroblasts
with TSA can induce senescence by derepressing CKIs
[40]. We thus chose to test the effect of TSA on
DNA compaction and H4-K16Ac deacetylation by
first inducing senescence by activated RAF1 kinase
for 3 days, and then treating the senescent cells with
TSA (410 nM) for 24 hours. Histone profiling by
mass spectrometry showed that TSA had a remark-
ably specific effect on augmenting principally mono-
acetyl-lysine-H4 under these conditions (Figure 9A,B).
Immunoblotting confirmed that this corresponded to
an increase in the preponderant acetylation of H4-
K16 (Figure 9C). Increased H4-K16Ac in the senes-
cent cells was accompanied by decompaction of DNA
(Figure 9D,E). Furthermore, washing out the TSA led
to a rapid recompaction of the DNA by 1 hour
(Figure 9F). These observations indicate that class I/II
HDACs contribute to the dynamic maintenance of
H4-K16Ac deacetylation and DNA compaction in sen-
escent cells.Oncogene-induced senescence is not universally
associated with loss of H4-K16Ac and assembly of striking
SAHFs
It was recently reported that the level of H4-K16Ac
could distinguish replicative senescence from RASval12-
induced senescence of human BJ foreskin fibroblasts
[18]. By immunoblot analyses, replicatively senescent BJ
fibroblasts were found to have lower levels of H4-K16
acetylation than proliferating BJ cells, as we observed for
WI-38 fibroblasts. However, in contrast to RAF-induced
senescence of WI-38, it was reported that RASval12-
induced senescence of BJ fibroblasts was associated with
an increase rather than a decrease of H4-K16 acetylation
compared to proliferating cells. We considered that this
difference might be due to the cell line, the hTERT
immortalization, or the oncogene used to trigger senes-
cence. We thus measured H4-K16 acetylation in non-
immortalized BJ and IMR-90 fibroblasts expressing an
ER-RASval12 fusion protein that can trigger senescence
after activation of RASval12 by the addition of 4-HT
[41]. IMR-90/ER-RASval12 cells senesced with well-
developed SAHFs (Figure 10A,B) accompanied by a
decrease in H4-K16 acetylation as for RAF-senescent
WI-38hTERT cells (Figure 10C,D). In striking contrast,
the BJ cells induced into senescence by RASval12
showed increased H4-K16Ac compared to proliferating
BJ cells (Figure 10C,D), and the chromatin of RAS-
senescent BJ cells was not as compact (Figure 10A,B)
as that of RAS-senescent IMR-90 or RAF-senescent
WI-38hTERT cells. Narita and colleagues also
reported reduced DNA compaction for BJ versus
IMR-90 cells induced into senescence by RASval12
[23]. These results indicate that loss of H4-K16Ac is
not universally associated with cellular senescence,
and the increased H4-K16Ac of BJ cells during RAS-
induced senescence is not characteristic of RAS-
induced senescence but rather appears to be specific to
this cell line. Senescent BJ fibroblasts also express the
HMGA2 chromatin protein [24] and the p16 CDK in-
hibitor [42,43] at lower levels than other fibroblasts.
Thus, male BJ foreskin fibroblasts differ by several cri-
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Figure 6 SIRT2 contributes to deacetylation of H4-K16Ac and DNA compaction during RAF-induced senescence. A) Immunoblot of
extracts from WI-38hTERT/GFP-RAF-ER cells treated with siRNA (24 hours) and 20 nM 4-HT (3 days) using anti-SIRT1, -SIRT2, -MOF, -GAPDH
(loading control), -H4-K16Ac, -H3 (loading control) antibodies. Two independent experiments are shown for the depletion of SIRT2. B) Boxplots of
4',6'-diamidino-2-phenylindole coefficient of variation (DAPI CV) (n > 70, from one experiment). *DNA compaction statistically different from No
Target (P< 10-5, Welch t-test). Biological replicates are shown Figure 7B. C) mRNA level of SIRT2 by qPCR after siRNA treatment (24 hours) and 20
nM 4-HT (6 hours). D) Immunoblot of WI-38hTERT/GFP-RAF-ER cells treated with 20 nM 4-HT for the indicated times using anti-SIRT1, -SIRT2,
-MOF and -GAPDH (loading control) antibodies. Histogram shows the normalized level of SIRT2 to GAPDH for two independent time courses. E)
Relative abundance of H4 acetylation states measured at the protein level on deconvoluted mass spectra. Error bars show SD of three biological
replicates. F) Boxplots of DAPI CV (n > 60, from one experiment). *DNA compaction statistically different from Prolif. (P< 10-5, Welch t-test). Prolif.:
proliferating WI-38hTERT/GFP-RAF-ER.
Contrepois et al. Epigenetics & Chromatin 2012, 5:15 Page 9 of 19
http://www.epigeneticsandchromatin.com/content/5/1/15Finally, we examined H4-K16Ac levels and DNA com-
paction during RAF-induced senescence of an hTERT-
immortalized retinal pigmented epithelial (RPE) cell line.
As for the RAF-induced senescence of WI-38hTERT
cells, we observed a decrease in levels of H4-K16Ac
during RAF-induced senescence of RPEhTERT cells
(Figure 11A). However, DNA compaction was lessevident in these cells compared to WI-38hTERT
(Figures 11B,C and 10A,B). Chromatin preparations
showed that similar to BJ fibroblasts, RAF-senescent RPEh-
TERT cells contained lower levels of HMGA2 than RAF-
senescent WI-38hTERT or RAS-senescent IMR-90 cells
(Figure 11D). We explored the effects of H4-K16Ac and
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Figure 7 Effect of SIRT1, SIRT2, and MOF depletion, and sirtuin inhibitors on DNA compaction during RAF-induced senescence of WI-
38hTERT/GFP-RAF-ER. A) DNA 4',6'-diamidino-2-phenylindole (DAPI) staining of representative nuclei and corresponding DAPI coefficient of
variation (CV) values (from Figure 6B). B) Boxplots of DAPI CV (n > 60, three experiments are shown). *DNA compaction statistically different from
No Target (P< 10–5, Welch t-test). C) DNA DAPI staining of representative nuclei and corresponding DAPI CV values. D) Boxplots of DAPI CV
(n > 80, from one experiment). *DNA compaction statistically different from solvent DMSO control (P< 10–5, Welch t-test). E) Immunoblot
showing the level of H4-K16Ac in acid-extracted histones. Loading control: H3. DMSO: WI-38hTERT/GFP-RAF-ER + 0.1% dimethyl sulfoxide
(DMSO) + 20 nM 4-HT (3 days); Salermide: WI-38hTERT/GFP-RAF-ER + 50 μM salermide + 20 nM 4-HT (3 days); Sirtinol: 25 μM sirtinol + 20 nM 4-HT
(3 days).
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siRNA depletion of MOF with ectopic expression of
HMGA1 or HMGA2. Knockdown of MOF decreased the
level of H4-K16Ac and increased DNA compaction
(Figure 11E,F,G). Ectopic expression of either HMGA1 or
HMGA2 also increased DNA compaction. Remarkably, ec-
topic expression of HMGA1 or HMGA2 in combination
with MOF depletion synergistically increased DNA com-
paction leading to the formation of striking SAHFs
(Figure 11F,G). We conclude that deacetylation of H4-K16Ac and expression of HMGA1/2 can both contribute
to DNA compaction during senescence.
Discussion
Deacetylation of H4-K16Ac is associated with chromatin
compaction in vitro, transcriptional silencing in yeast,
and X chromosome inactivation in female humans. We
show here that it also occurs during replicative senes-
cence, and is required for the extreme DNA compaction
associated with the oncogene-induced senescence (OIS)
Table 1 Depletion of SIRT2 mRNAs or treatment with
sirtuin inhibitors does not induce senescence of
proliferating cells and does not inhibit RAF-induced
senescence as determined by 5-bromo-2'-deoxyuridine
(BrdU) incorporation
Experiment Insult 4-HT (20 nM) BrdU-positive cells (%)
siRNA No Target + < 1
- 75
SIRT2 + < 1
- 89
Sirtuin inhibitors DMSO + < 1
(1/1000) - 89
Salermide + < 1
(50 μM) - 18
Sirtinol + < 1
(25 μM) - 29
WI-38hTERT/GFP-RAF-ER cells were treated with the indicated siRNAs or sirtuin
inhibitors in the presence or absence of 20 nM 4-HT for 3 days and then with
fresh medium for 4 days. Cells treated with siRNAs were incubated with BrdU
for 24 hours and cells treated with sirtuin inhibitors for 3 days to determine
the percentage of cells able to enter S phase under these conditions.
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SAHFs. In the latter process, SIRT2, but not SIRT1, par-
ticipates in the global deacetylation of H4-K16Ac.
We showed that oncogene-induced senescence of
IMR-90 and WI-38hTERT female human embryonic
lung fibroblasts was accompanied by a decrease in
H4-K16Ac and highly developed SAHFs. BlockingFigure 8 Effect of SIRT2 depletion on the reversion of RAF-
induced senescence after cyclin-dependent kinase inhibitor
(CKI) knockdown. WI-38hTERT/GFP-RAF-ER cells were transfected
(24 hours) and induced into senescence by treatment with 20 nM 4-
HT for 3 days. Senescent cells were then transfected with the
indicated siRNAs and cells were incubated for a further 3 days
before testing their capacity to incorporate 5-bromo-2'-deoxyuridine
(BrdU) during an additional 24-hour incubation. Error bars show SD
of two biological replicates.deacetylation of H4-K16Ac inhibited DNA compaction,
but did not noticeably affect the entry or the mainten-
ance of senescence. Stable local repression of cell prolif-
eration genes by the Rb family is clearly required for the
entry and maintenance of senescence [23], but this
process does not appear to require extensive global com-
paction of the genome in the form of highly developed
SAHFs [42,44]. Surprisingly, the OIS of male BJ foreskin
fibroblasts was accompanied by an increase in H4-
K16Ac and less highly compacted DNA. We found that
levels of global H4-K16Ac depend on a dynamic balance
between MOF HAT activity and the deacetylase activities
of SIRT2 and TSA-sensitive class I/II enzymes. The TSA
sensitive enzymes are probably HDAC1 and HDAC2,
which have been previously implicated in contributing
to global levels of H4-K16Ac [18]. This dynamic balance
thus appears to be regulated in a cell-type specific fash-
ion during OIS even between seemingly very similar
fibroblasts. In contrast, replicative senescence of both
WI-38 and BJ fibroblasts was accompanied by a decrease
in H4-K16Ac. Although morphologically very similar,
fibroblasts derived from different anatomical locations
retain characteristic epigenetic patterns of gene expres-
sion during in vitro culture [45]. Differences due to
tissue origin or stage of development, gender, or inad-
vertent in vitro selection during the propagation of cell
lines may explain the different epigenetic responses of
fibroblasts during OIS.
We also found that RAF-induced senescence of retinal
pigmented epithelial cells was associated with a decrease
in H4-K16Ac, but only low levels of DNA compaction.
We found that HMGA2 was poorly expressed in these
cells, as is the case for BJ fibroblasts. Remarkably, ectopic
expression of HMGA1 or HMGA2 in combination with
siRNA depletion of MOF to further decrease H4-K16Ac
levels led to a synergistic increase in DNA compaction
and the formation of striking SAHFs. Thus, we identified
two crucial factors contributing to cell-type specificity in
heterochromatin assembly during senescence.
Deregulation of chromatin structure, and H4-K16
acetylation in particular, has been implicated in both
aging and cancer. In budding yeast, aging has been asso-
ciated with a loss of the Sir2 deacetylase and subsequent
increase of H4-K16Ac and loss of transcriptional silen-
cing [46]. Overexpression of Sir2 increases the replica-
tive life span of yeast, and this observation led to an
explosion of interest in the sirtuin family of NAD-
dependent deacetylases. However, the premature aging
observed in a progeroid mouse model was associated
with hypoacetylation of H4-K16 [47]. Treatment of these
mice with the histone deacetylase inhibitor sodium bu-
tyrate extended their lifespan. Furthermore, a decrease
in mono-acetylated H4 was observed in rat brain cortical
neurons during development and aging [48]. Since K16
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studied organisms [49], this observation suggests that
loss of H4-K16Ac occurs progressively in aging post-
mitotic cortical neurons. We observed a decrease ofC 
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Figure 9 (See legend on next page.)H4-K16Ac during the replicative senescence of WI-38
fibroblasts that is consistent with a reported decrease
during the replicative senescence of BJ fibroblasts [18].
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Figure 9 Treatment of senescent cells with trichostatin A (TSA) increases H4-K16Ac and decreases DNA compaction in a rapid and
reversible manner. A) Deconvoluted mass spectra of intact core histones in senescent cells treated with dimethyl sulfoxide (DMSO) or TSA for
24 hours. For each acetylation state of H4, unmodified, mono- and di-methylated K20 forms are visible. B) Relative abundance of H4 acetylation
states measured at the protein level on deconvoluted mass spectra (Figure 9A). Error bars show SD of two biological replicates. C)
Immunoblotting analyses of H4-K12Ac, H4-K16Ac and H3 (loading control). D) DNA 4',6'-diamidino-2-phenylindole (DAPI) staining of
representative nuclei and corresponding DAPI coefficient of variation (CV) values. E) Boxplots of DAPI CV (n > 110, from one experiment). *DNA
compaction statistically different from solvent DMSO control (P< 10-5, Welch t-test). F) DNA DAPI staining of representative nuclei from senescent
cells that had been treated with TSA for 24 hours and then washed to remove TSA and further incubated with fresh medium for 1 or 6 hours.
DMSO: WI-38hTERT/GFP-RAF-ER + 20 nM 4-HT (3 days) + 0.1% dimethyl sulfoxide (DMSO) 24 hours; TSA: WI-38hTERT/GFP-RAF-ER + 20 nM 4-HT
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Figure 10 Oncogene-induced senescence is not universally associated with H4-K16Ac deacetylation and striking senescence-associated
heterochromatin foci (SAHFs). A) DNA 4',6'-diamidino-2-phenylindole (DAPI) staining of representative nuclei and corresponding DAPI
coefficient of variation (CV) values. B) Boxplots of DAPI CV (n > 60, from one experiment). *DNA compaction statistically different from Prolif.
(P< 10-5, Welch t-test). C) Relative abundance of H4 acetylation states measured at the protein level on deconvoluted mass spectra. Error bars
show SD of at least two biological replicates. D) Immunoblot showing the level of H4-K16Ac in acid-extracted histones. Loading control:
Coomassie blue staining of histones. WI-38 SenRAF: WI-38hTERT/GFP-RAF-ER + 4-HT 20 nM (5 days); IMR-90 SenRAS: IMR-90/ER-RASval12 + 4-HT
100 nM (6 days); BJ SenRAS: BJ/ER-RASval12 + 4-HT 100 nM (5 days).
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Figure 11 (See legend on next page.)
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Figure 11 H4-K16Ac and HMGA proteins act synergistically in DNA compaction leading to the formation of striking senescence-
associated heterochromatin foci (SAHFs). A) Deconvoluted mass spectra of intact histone H4 in proliferating and RAF-senescent RPEhTERT. B)
DNA 4',6'-diamidino-2-phenylindole (DAPI) staining of representative nuclei and corresponding DAPI coefficient of variation (CV) values. C)
Boxplots of DAPI CV (n > 80, from one experiment). *DNA compaction statistically different from retinal pigmented epithelial (RPE) Prolif. (P< 10-5,
Welch t-test). D) SDS-PAGE of acid-extracted proteins from proliferating and oncogene-induced senescent WI-38hTERT, IMR-90, BJ and RPEhTERT
cells. E) Immunoblot of extracts from RPEhTERT/RAF-ER cells treated with siRNA (24 hours) and 20 nM 4-HT (6 days) using anti-MOF, -GAPDH
(loading control), -H4-K16Ac, -H3 (loading control) antibodies. F) DNA DAPI staining of representative nuclei and corresponding DAPI CV values.
G) Boxplots of DAPI CV (n > 50, from one experiment). *DNA compaction statistically different from No Target - pWZL Ctl (P< 10-5, Welch t-test).
WI-38 SenRAF: WI-38hTERT/GFP-RAF-ER + 4-HT 20 nM (5 days); IMR-90 SenRAS: IMR-90/ER-RASval12 + 4-HT 100 nM (6 days); BJ SenRAS: BJ/ER-
RASval12+ 4-HT 100 nM (5 days); RPE SenRAF: RPEhTERT/GFP-RAF-ER+ 4-HT 100 nM (6 days).
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matic mark. These results suggest that heterochromatin
formation may increase during aging of mammalian cells,
consistent with some studies involving other heterochro-
matic features, such as H4-K20Me3 [50], and macro-
H2A and HP1-beta [51]. However, another study
reported a reduction of yet other heterochromatic fea-
tures (H3-K9Me3 and HP1-gamma) in aging human
fibroblasts [52]. These results are not necessarily mutu-
ally exclusive and it is possible that aging chromatin is
not subject to overall gain or loss of heterochromatin,
but rather a more complex set of perturbations that must
be characterized at the level of individual marks.
The replicative senescence of budding yeast appears to
involve the loss of Sir2 that leads to increases in
H4-K16Ac and heterochromatin defects [53]. Depletion
of SIRT1, the human sirtuin that is most closely related
to Sir2, also accelerates the replicative senescence of
human fibroblasts, but this appears to be due to hypera-
cetylation and activation of the DNA damage checkpoint
effector p53 [54]. During RAF-induced senescence of
WI-38hTERT fibroblasts, we observed loss of H4-K16Ac
that was independent of SIRT1. In contrast, knockdown
of SIRT2 prevented loss of H4-K16Ac during RAF-
induced senescence and inhibited DNA compaction.
SIRT2 is largely cytosolic in interphase cells, but shuttles
between the nucleus and cytoplasm [19]. We did not ob-
serve a change in its intracellular localization during
RAF-induced senescence (unpublished data). SIRT2 has
important mitotic functions in deacetylating global
H4-K16Ac [16] and in activating the APC (anaphase
promoting complex) [55]. SIRT2 activity is inhibited by
Cdk2-cyclin A/E phosphorylation [56,57], so that SIRT2
activity may be highest in the M and early G1 phases of
cycling cells that do not express these cyclins. During
RAF-induced senescence, we observed a slight and early
increase in SIRT2 levels that was correlated with an
early and progressive loss of H4-K16Ac. It is also likely
that SIRT2 activity is increased during senescence by the
loss of cyclin A/E whose expression is repressed by the
retinoblastoma pathway [58].
Cancer is largely a disease of aging involving the accu-
mulation of genetic and epigenetic modifications thatfavor uncontrolled growth and metastasis of rogue cells.
Interestingly, loss of H4-K16Ac has been reported in
cancer cells relative to normal cells [59], although some
aspects of this work are controversial and merit further
study [13,32]. This observation could be interpreted in
several ways. Since cancer arises mainly in the elderly,
the decreased H4-K16Ac in cancer cells may reflect loss
of H4-K16Ac during the aging of progenitor cells. An-
other possibility is that decreased H4-K16Ac favors car-
cinogenesis by decreasing the efficiency of DNA repair
and thereby increasing genomic instability [12,14,15,47].
Finally, decreased H4-K16Ac may be related to yet an-
other aspect of the past history of the cancer cell.
Expression of mitogenic oncogenes in normal human
cells can lead to the induction of cellular senescence as a
tumor suppressor mechanism that prevents unscheduled
cellular proliferation. Such senescence can be induced in
at least two ways. Cancer progenitor cells that do not
express telomerase will eventually undergo senescence
by loss of telomeric sequences, and we have shown that
replicatively senescent cells have decreased H4-K16Ac.
In other cell types, hyper-mitogenic signaling induced by
oncogene expression induces a rapid senescence even in
cells that express telomerase. We showed that such sen-
escence in WI-38hTERT or IMR-90 fibroblasts is also
accompanied by a decrease in H4-K16Ac. In both
instances, cancer progression requires bypass or escape
from senescence [21]. Such cells may nevertheless retain
decreased levels of H4-K16Ac. Two papers suggest that
cancer cells that escape from senescence may be selected
to retain enhanced heterochromatin in order to reduce
DNA damage signaling and avoid apoptosis [42,44]. Our
observation of reduced H4-K16Ac in many senescent
cells, and previous work describing reduced H4-K16Ac
in cancer cells [59], would be consistent with this
hypothesis. However, this idea was based on the postu-
late that DNA damage in heterochromatin is poorly
detected and inefficiently activates DNA damage check-
point signaling. Recent data indicate that heterochro-
matic DNA lesions are in fact detected very efficiently
and the damaged DNA is very rapidly transported to the
euchromatic boundary for repair [60,61]. It is thus not
clear that increased heterochromatin content would
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ing engendered by replication stress and genomic in-
stability. Further work should clarify the respective roles
of evolutionary history and selective pressures in modu-
lating H4-K16Ac levels and heterochromatin formation
in cancer.
Conclusions
Variable DNA compaction observed during senescence
is explained in part by cell-type specific regulation of H4
deacetylation and HMGA1/2 expression. SIRT2 and
TSA-sensitive HDACs participate in global deacetylation
of H4-K16Ac during RAF-induced senescence, but not
SIRT1. Deacetylation of H4-K16Ac during senescence
may explain reported decreases in this mark during
mammalian aging and in cancer cells.
Methods
Cell lines and retroviruses
WI-38hTERT human embryonic fibroblasts expressing a
conditionally activated form of the RAF1 kinase (GFP-
RAF-ER) were obtained and cultured as described [29].
RPEhTERT/GFP-RAF-ER cells were produced in a simi-
lar fashion. WI-38 cells were passaged in ambient 20%
oxygen and 5% CO2 to obtain a replicatively senescent
population at PD 65. IMR-90 and BJ cells expressing ER-
RASval12 were grown as described [41]. Retroviral pre-
parations of pWZL, pWZL-HMGA1, and pWZL-
HMGA2 were prepared as described [24].
Preparation of histones and mass spectrometry analyses
Histones were acid-extracted from various fibroblast cell
lines in different conditions and analyzed by MS and
MS/MS both at the intact protein and the tryptic pep-
tide levels as previously described [28]. Relative quantifi-
cation of histone modified forms/variants was measured
on deconvoluted ultra-high performance liquid chroma-
tography (UHPLC)-MS spectra by dividing the intensity
of a given MS peak by the sum of the intensities of the
different MS peaks composing the spectrum of a consid-
ered histone. For typtic peptide analyses, histones were
first propionylated on lysine residues, then digested with
trypsin, and finally subjected to a second round of pro-
pionylation to block the newly formed N-terminal resi-
dues. Analyses were then performed on a LTQ-Orbitrap
Discovery mass spectrometer that was operated in the
data-dependent acquisition mode, allowing the auto-
matic switching between MS and MS/MS. The MS sur-
vey scan was performed from m/z 300 to 2000 in the
Orbitrap, using a resolution set at 30,000 (at m/z 400).
The five most abundant ions (threshold 500 counts,
charge states higher than +1) were further selected for
collision-induced dissociation (CID) experiments. The
CID fragment ions were detected in the linear ion trap.Relative quantification of histone modifications was
determined by measuring the area of the extracted ion
chromatogram peak corresponding to a specific modi-
fied peptide normalized to the sum of the peak areas
corresponding to all observed modified forms of this
peptide.
Chemicals
Chemicals were prepared as 1000× stock solutions in
the indicated solvents and stored at −20°C. 4-HT
(Sigma-Aldrich H6278, Saint Quentin Fallavier, France)
was dissolved in ethanol. Etoposide (Sigma-Aldrich
E1383), TSA (Sigma-Aldrich T8552), sirtinol (Santa Cruz
Biotechnology sc-205976, Santa Cruz, CA), and sale-
rmide (Santa Cruz Biotechnology sc-224276 ) were solu-
bilized in DMSO.
Flow cytometry analyses of DNA content
DNA content analyses were performed with a FACS
Calibur flow cytometer [29].
BrdU incorporation and immunostaining
Cells were seeded in 24-well plates at a density of 50,000
cells/well on collagen-treated coverslips. BrdU was
added to media at a final concentration of 50 μM for the
indicated periods of time. Immunofluorescence to
visualize incorporated BrdU and/or intracellular proteins
was performed as described [29] using mouse anti-BrdU
(BD Biosciences 555627, San Jose, CA) and rabbit anti-
phospho-T68-Chk2 (Cell Signaling Technology 2661,
Danvers, MA) under conditions suggested by the
manufacturer. We used mouse anti-γH2AX antibodies
(Millipore 05–636, Billerica, MA) diluted 1/500 with
an incubation of 1 hour at room temperature to
visualize γH2AX foci within cells. For DAPI staining,
permeabilized cells were treated for 1 minute with
0.5 μg/ml DAPI and then washed with PBS before
mounting with Prolong Gold anti-fade medium (Invi-
trogen). Images of DAPI-stained nuclei were taken
with a LEICA DMIRE2 microscope equipped with a
63x/1.4 oil immersion objective, a Roper Instruments
CCD camera and Metamorph software (Universal Im-
aging Corporation Ltd.).
Quantification of DNA compaction
We designed a plugin for ImageJ that semi-automatically
identifies DAPI-stained nuclei and then calculates the
CV for DAPI fluorescent intensities for all pixels within
each nucleus as a quantitative metric of DNA compac-
tion. We verified that the DAPI CV was independent of
exposure time for images that did not contain saturated
pixels and that had an empirically determined range of
signal intensities. As shown in Figure 1C, we observed a
significant difference in CV distribution in proliferating
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puts individual images of all segmented nuclei into an
array containing the DAPI CV for all nuclei. The plugin
is available upon request.
Data analysis and statistics
The DAPI CV was calculated for the indicated number
of nuclei from one experiment. DAPI CV results are
presented as boxplots (with 95% confidence levels and
analyzed by the Welch t-test). A box represents 50% of
the data and the median. Whiskers correspond to the
minimum and maximum values. Histone PTM relative
abundances were presented on histograms as the average
values and SD for the indicated number of biological
replicates.
siRNA transfection
Fibroblasts were transfected with Dharmafect 4 reagent
(ThermoFisher Scientific, Surrey, UK) according to the
manufacturer’s protocol. We used 100 nM of siGenome
SMARTPOOL RNAs for SIRT1 and MOF. SIRT2 was
depleted using 50 nM siON-TARGET plus SMART-
POOL and 50 nM siGenome SMARTPOOL RNAs. The
control consisted of 100 nM of non-targeting siGenome
SMARTPOOL RNAs. Twenty-four hours after transfec-
tion, senescence was induced by adding 20 nM 4-HT for
3 days. siRNA knockdown efficiency was confirmed by
immunoblotting. To test the effect of SIRT2 mRNA de-
pletion on the maintenance of senescence after CKI
knockdown, cells were transfected and induced into sen-
escence as described above. Senescent cells were then
transfected with either 100 nM siGenome SMARTPOOL
RNAs for p21, 100 nM siRNA sense-strand sequence
CCAACGCACCGAAUAGUUA for p16 or both and fur-
ther cultured in fresh medium without 4-HT for 4 days
(BrdU incorporation for 24 hours).
SDS-PAGE and western blotting
Whole cell extracts were prepared by resuspension of
cells in PBS supplemented with anti-protease cocktail
(Complete EDTA-free Protease Inhibitor Cocktail Tablets,
Roche, Meylan, France), phosphatase inhibitors (10 mM
orthovanadate and 20 mM β-glycero-phosphate) and
Laemmli 4× sample buffer. Samples were then heat-treated
for 10 minutes at 95°C and subsequently sonicated. Protein
concentrations were determined by Bradford assay. 10 to
20 μg whole cell protein extracts were separated by 12% or
8% SDS-PAGE and 1 to 2 μg acid-extracted histones were
separated by 15% SDS-PAGE. Blots were probed with the
following antibodies under manufacturers’ recommenda-
tions: rabbit anti-SIRT1 (Santa Cruz Biotechnology sc-
15404), mouse anti-SIRT2 (a generous gift from Danny
Reinberg’s lab), rabbit anti-MOF (Santa Cruz Biotechnology
sc-81765), rabbit anti-GAPDH (Abcam ab9485, Cambridge,United Kingdom), rabbit anti-H3 (Abcam ab1791), rabbit
anti-H4-K16Ac (Millipore 07–329), rabbit anti-H4-K12Ac
(Millipore 19982), rabbit anti-H4-K8Ac (Millipore 22720).
Washed membranes were then probed with secondary
antibodies conjugated to infrared dyes, scanned and ana-
lyzed with the Odyssey imaging system and its associated
software (Li-Cor).
Quantitative real-time (qRT)-PCR
The efficiency of siRNA depletion of SIRT2 mRNA was
assessed by qRT-PCR. 500,000 cells were transfected and
senescence was induced 24 hours after transfection for
6 hours by adding 20 nM 4-HT to the cell medium.
Total RNA was isolated using a Nucleospin RNA XS kit
(Macherey-Nagel, Hœrdt, France). qRT-PCR was per-
formed on a Bio-Rad iQ5 instrument. The reactions
were prepared using Platinum SYBR Green qPCR
SuperMix-UDG (Invitrogen 11733–046, Cergy Pontoise,
France). GAPDH was used as a control gene for
normalization. Primer sequences for qRT-PCR: GAPDH-
for, ATGGGGAAGGTGAAGGTCG ; GAPDH-rev, GG
GGTCATTGATGGCAACAATA ; SIRT2-for, AGGCCA
AGGCTTAAACAGGCATC ; SIRT2-rev, TCCTTAGCC
CAGGAGTGG TTAGAG.
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